BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28840297)

  • 1. Therapeutic antibodies against cancer stem cells: a promising approach.
    Sneha S; Nagare RP; Priya SK; Sidhanth C; Pors K; Ganesan TS
    Cancer Immunol Immunother; 2017 Nov; 66(11):1383-1398. PubMed ID: 28840297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells.
    Yang W; Kim D; Kim DK; Choi KU; Suh DS; Kim JH
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in cancer drug resistance reversal strategies using nanoparticles.
    Palakurthi S; Yellepeddi VK; Vangara KK
    Expert Opin Drug Deliv; 2012 Mar; 9(3):287-301. PubMed ID: 22339554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
    Oh J; Hlatky L; Jeong YS; Kim D
    Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cancer stem cell markers: Progression and therapeutic implications.
    Sun JH; Luo Q; Liu LL; Song GB
    World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells--important players in tumor therapy resistance.
    Colak S; Medema JP
    FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell-targeted therapeutics and delivery strategies.
    Ahmad G; Amiji MM
    Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells targeting agents--a review.
    Shi AM; Tao ZQ; Li H; Wang YQ; Zhao J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4064-7. PubMed ID: 26592827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.